685.1000 1.65 (0.24%)
NSE Nov 28, 2025 15:31 PM
Volume: 112.6K
 

Axis Direct
We believe KIMS has a structural growth story (strong ROCE of 32%). It is also a zero net-debt company due to its strong operating cash flow generation. Keeping this in perspective, we recommend a BUY rating on the stock with a TP of Rs 1,570/share.
Krishna Institute of Medical Sciences Ltd. is trading below its 30 day SMA of 700.6
More from Krishna Institute of Medical Sciences Ltd.
Recommended